No Data
Here's Why Guilin Sanjin Pharmaceutical (SZSE:002275) Can Manage Its Debt Responsibly
Guilin Sanjin (002275.SZ): The company's actual controlling person and chairman, the director's shareholding plan has been completed, with a cumulative increase of 0.383 million shares.
Guilin Sanjin (002275.SZ) announced on September 2nd that the company disclosed the "Announcement on the Plan of the Actual Controller, Chairman, and CEO to Increase the Company's Shareholding" on March 2nd, 2024. Mr. Zou Xun, the actual controller, chairman, and CEO of the company, plans to use his own funds to increase his shareholding in the company through centralized bidding or bulk trading on the Shenzhen Stock Exchange within six months starting from March 2nd, 2024. The amount of the shareholding increase will not be less than 5 million RMB. From March 2nd, 2024 to September 1st, 2024, Mr. Zou Xun has increased his shareholding in the company through centralized bidding on the Shenzhen Stock Exchange.
Guilin Sanjin: Semi-Annual Report 2024
Guilin Sanjin: 2024 Semi-Annual Report Summary
Guilin Sanjin Pharmaceutical (002275.SZ) announced its performance for the first half of the year, with a net income of 0.301 billion yuan, a decrease of 20.70%.
Guilin Sanjin (002275.SZ) released the 2024 interim report, during the reporting period, the company achieved revenue...
Guilin Sanjin Pharmaceutical (002275.SZ): net income of 0.301 billion yuan in the first half of the year, a year-on-year decrease of 20.70%.
Guilin Sanjin (002275.SZ) released its interim report for the first half of 2024, with operating revenue of 1.068 billion yuan, a decrease of 10.53% year-on-year. The net income attributable to shareholders of the listed company was 0.301 billion yuan, a decrease of 20.70% year-on-year. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.274 billion yuan, a decrease of 25.21% year-on-year. The basic earnings per share was 0.51 yuan.
Guilin Sanjin Pharmaceutical Co., Ltd. (SZSE:002275) Looks Inexpensive But Perhaps Not Attractive EnoughNo Data
No Data
